227 related articles for article (PubMed ID: 22122967)
1. Initial experience of conversion of Toyobo paracorporeal left ventricular assist device to DuraHeart left ventricular assist device.
Yoshioka D; Sakaguchi T; Saito S; Miyagawa S; Nishi H; Yoshikawa Y; Fukushima S; Ueno T; Kuratani T; Sawa Y
Circ J; 2012; 76(2):372-6. PubMed ID: 22122967
[TBL] [Abstract][Full Text] [Related]
2. DuraHeart™ magnetically levitated left ventricular assist device: Osaka University experience.
Sakaguchi T; Matsumiya G; Yoshioka D; Miyagawa S; Nishi H; Yoshikawa Y; Fukushima S; Saito S; Ueno T; Sawa Y
Circ J; 2013; 77(7):1736-41. PubMed ID: 23595087
[TBL] [Abstract][Full Text] [Related]
3. Midterm outcome of implantable left ventricular assist devices as a bridge to transplantation: Single-center experience in Japan.
Kimura M; Kinoshita O; Nawata K; Nishimura T; Hatano M; Imamura T; Endo M; Kagami Y; Kubo H; Kashiwa K; Kinugawa K; Kyo S; Komuro I; Ono M
J Cardiol; 2015 May; 65(5):383-9. PubMed ID: 25034705
[TBL] [Abstract][Full Text] [Related]
4. [Bridge to bridge surgery;conversion from extracorporeal left ventricular assist device to implantable left ventricular assist device].
Kinoshita O; Ono M
Kyobu Geka; 2013 Jul; 66(8 Suppl):690-5. PubMed ID: 23917187
[TBL] [Abstract][Full Text] [Related]
5. A retrospective study of left ventricular assist device-related infections.
Bentz B; Hupcey JE; Polomano RC; Boehmer JP
J Cardiovasc Manag; 2004; 15(1):9-16. PubMed ID: 14976692
[TBL] [Abstract][Full Text] [Related]
6. Biventricular support using implantable continuous-flow ventricular assist devices.
Saito S; Sakaguchi T; Miyagawa S; Yoshikawa Y; Yamauchi T; Ueno T; Kuratani T; Sawa Y
J Heart Lung Transplant; 2011 Apr; 30(4):475-8. PubMed ID: 21295496
[TBL] [Abstract][Full Text] [Related]
7. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
[TBL] [Abstract][Full Text] [Related]
8. Successful management of apical abscess after Nipro left ventricular assisted device explantation by removal of apical cuff and omentopexy.
Yoshitake S; Itoda Y; Nawata K; Iwase T; Hoshino Y; Kimura M; Kinoshita O; Yamauchi H; Ono M
J Artif Organs; 2016 Dec; 19(4):396-398. PubMed ID: 27507585
[TBL] [Abstract][Full Text] [Related]
9. Covering implantable left ventricular assist device (DuraHeart) with free flap.
Matsuda K; Nishibayashi A; Toda K; Fujiwara T; Fukai M; Yoshioka D; Sawa Y; Hosokawa K
J Artif Organs; 2015 Jun; 18(2):114-9. PubMed ID: 25535105
[TBL] [Abstract][Full Text] [Related]
10. [Ventricular assist device].
Kyo S; Takamoto S
Kyobu Geka; 2009 Jul; 62(8 Suppl):704-11. PubMed ID: 20715696
[TBL] [Abstract][Full Text] [Related]
11. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
Topkara VK; Kondareddy S; Malik F; Wang IW; Mann DL; Ewald GA; Moazami N
Ann Thorac Surg; 2010 Oct; 90(4):1270-7. PubMed ID: 20868826
[TBL] [Abstract][Full Text] [Related]
12. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
13. Current status of third-generation implantable left ventricular assist devices in Japan, Duraheart and HeartWare.
Sawa Y
Surg Today; 2015 Jun; 45(6):672-81. PubMed ID: 25139211
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and prognostic impact of left ventricular assist device-associated infections.
Tattevin P; Flécher E; Auffret V; Leclercq C; Boulé S; Vincentelli A; Dambrin C; Delmas C; Barandon L; Veniard V; Kindo M; Cardi T; Gaudard P; Rouvière P; Sénage T; Jacob N; Defaye P; Chavanon O; Verdonk C; Para M; Pelcé E; Gariboldi V; Pozzi M; Grinberg D; Savouré A; Litzler PY; Babatasi G; Belin A; Garnier F; Bielefeld M; Hamon D; Lellouche N; Bernard L; Bourguignon T; Eschalier R; D'Ostrevy N; Jouan J; Varlet E; Vanhuyse F; Blangy H; Martins RP; Galand V
Am Heart J; 2019 Aug; 214():69-76. PubMed ID: 31174053
[TBL] [Abstract][Full Text] [Related]
15. Successful use of the Toyobo left ventricular assist device in a 16-kg girl awaiting cardiac transplantation.
Masuoka A; Katogi T; Asano H; Iwazaki M; Matsuoka T; Nishimura M; Kyo S
Ann Thorac Surg; 2007 Mar; 83(3):1181-3. PubMed ID: 17307490
[TBL] [Abstract][Full Text] [Related]
16. Device exchange after primary left ventricular assist device implantation: indications and outcomes.
Stulak JM; Cowger J; Haft JW; Romano MA; Aaronson KD; Pagani FD
Ann Thorac Surg; 2013 Apr; 95(4):1262-7; discussion 1267-8. PubMed ID: 23063192
[TBL] [Abstract][Full Text] [Related]
17. New era for therapeutic strategy for heart failure: destination therapy by left ventricular assist device.
Kyo S; Minami T; Nishimura T; Gojo S; Ono M
J Cardiol; 2012 Mar; 59(2):101-9. PubMed ID: 22326458
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular assist device-related infection: treatment and outcome.
Simon D; Fischer S; Grossman A; Downer C; Hota B; Heroux A; Trenholme G
Clin Infect Dis; 2005 Apr; 40(8):1108-15. PubMed ID: 15791509
[TBL] [Abstract][Full Text] [Related]
19. Fifteen-year experience with Toyobo paracorporeal left ventricular assist system.
Saito S; Matsumiya G; Sakaguchi T; Fujita T; Kuratani T; Ichikawa H; Sawa Y
J Artif Organs; 2009; 12(1):27-34. PubMed ID: 19330502
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular implantable electronic device infections in left ventricular assist device recipients.
Riaz T; Nienaber JJ; Baddour LM; Walker RC; Park SJ; Sohail MR
Pacing Clin Electrophysiol; 2014 Feb; 37(2):225-30. PubMed ID: 23998684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
